home / stock / kblmr / kblmr quote
Last: | $0.392 |
---|---|
Change Percent: | 3.19% |
Open: | $0.379 |
Close: | $0.392 |
High: | $0.4101 |
Low: | $0.3211 |
Volume: | 959,383 |
Last Trade Date Time: | 11/06/2020 04:56:23 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.392 | $0.379 | $0.392 | $0.4101 | $0.3211 | 959,383 | 11-06-2020 |
$0.3799 | $0.35 | $0.3799 | $0.38 | $0.3 | 164,204 | 11-05-2020 |
$0.3497 | $0.35 | $0.3497 | $0.3749 | $0.3312 | 46,660 | 11-04-2020 |
$0.38 | $0.3499 | $0.38 | $0.38 | $0.281 | 238,670 | 11-03-2020 |
$0.321 | $0.3544 | $0.321 | $0.3544 | $0.311 | 133,201 | 11-02-2020 |
$0.3399 | $0.34 | $0.3399 | $0.3401 | $0.2611 | 34,996 | 10-30-2020 |
$0.3599 | $0.321 | $0.3599 | $0.36 | $0.295 | 147,973 | 10-29-2020 |
$0.321 | $0.33 | $0.321 | $0.3599 | $0.311 | 19,744 | 10-28-2020 |
$0.32 | $0.3399 | $0.32 | $0.34 | $0.3111 | 66,663 | 10-27-2020 |
$0.3326 | $0.335 | $0.3326 | $0.3518 | $0.312 | 122,072 | 10-26-2020 |
$0.36 | $0.37 | $0.36 | $0.38 | $0.3301 | 210,518 | 10-23-2020 |
$0.3596 | $0.4 | $0.3596 | $0.4 | $0.35 | 163,255 | 10-22-2020 |
$0.361 | $0.37 | $0.361 | $0.3863 | $0.311 | 266,100 | 10-21-2020 |
$0.3749 | $0.39 | $0.3749 | $0.39 | $0.3504 | 193,711 | 10-20-2020 |
$0.39 | $0.4049 | $0.39 | $0.4049 | $0.3599 | 750,417 | 10-19-2020 |
$0.36 | $0.37 | $0.36 | $0.3899 | $0.34 | 235,312 | 10-16-2020 |
$0.3799 | $0.375 | $0.3799 | $0.3817 | $0.37 | 75,149 | 10-15-2020 |
$0.3833 | $0.38 | $0.3833 | $0.39 | $0.3499 | 417,342 | 10-14-2020 |
$0.3699 | $0.35 | $0.3699 | $0.38 | $0.32 | 373,037 | 10-13-2020 |
$0.3209 | $0.35 | $0.3209 | $0.36 | $0.28 | 1,334,400 | 10-12-2020 |
News, Short Squeeze, Breakout and More Instantly...
KBL Merger Corp. IV Rights Company Name:
KBLMR Stock Symbol:
NASDAQ Market:
NEW YORK, Oct. 23, 2020 (GLOBE NEWSWIRE) -- NetworkNewsAudio – 180 Life Sciences Corp., a clinical-stage biotechnology company that has entered into a definitive merger agreement with KBL Merger Corp. (NASDAQ: KBLM) (KBL Merger Corp. Rights NASDAQ: KBLMR) (KBL Merger Corp. Warra...
NEW YORK, Oct. 21, 2020 (GLOBE NEWSWIRE) -- via NetworkNewsWire — 180 Life Sciences Corp., a clinical-stage biotechnology company that has entered into a definitive merger agreement with KBL Merger Corp. (NASDAQ: KBLM) (KBL Merger Corp. Rights NASDAQ: KBLMR) (KBL Merger Corp. Warrant...
NEW YORK, Oct. 21, 2020 (GLOBE NEWSWIRE) -- via NetworkNewsWire — 180 Life Sciences Corp. today announces its placement in an editorial published by Network NewsWire ("NNW"), one of 50+ brands in the InvestorBrandNetwork (“IBN”), a multifaceted financial new...